Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension

Clinical trial NCT00424021 · COMPLETED

Trial details

NCT number: NCT00424021
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2003-04-01
Primary completion: 2009-12-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.